The Journal of Immunology, Vol 157, Issue 10 4717-4720, Copyright © 1996 by American Association of Immunologists

ARTICLES

Regional immunosuppression in esophageal squamous cancer: evidence from functional studies with matched lymph nodes

GC O'Sullivan, AR Corbett, F Shanahan and JK Collins
Department of Surgery, National University of Ireland, Cork.

Although production of immunosuppressive factor(s) by esophageal squamous cancer has been demonstrated, systemic immunosuppression occurs late. Whether local immunosuppression by tumor-derived factors occurs in vivo as a potential mechanism of escape from immune surveillance is unknown. We found that lymphocytes from nodes draining distal esophageal squamous tumors in 23 consecutive patients had depressed proliferative and cytotoxic responsiveness relative to both lymphocytes from a reference node outside the field of drainage and matched PBL from the same patient. In a subset of patients in which more than one tumor-draining node was examined, a radial or zonal immunosuppression relative to the primary tumor was evident. The findings were unrelated to surgery or anatomic location because all but 2 of 26 control patients with esophagogastric adenocarcinoma had normal or enhanced lymphocyte responsiveness in the tumor-draining node. The absence of overt or even micrometastatic nodal disease, as determined by immunostaining for cytokeratin expression, coupled with the long- term survival of several of the patients, strongly suggests that the immunosuppressive effect is due to mechanisms other than metastases, and may be a premetastatic occurrence. We conclude that regional immunesuppression does exist in patients with esophageal squamous cancer when systemic immunity is still well preserved. The local immune suppression inhibits the generation of lymphokine-activated killer (LAK) cells and may be an impediment to potential immunotherapeutic strategies.

This article has been cited by other articles:

				B. Negin, D. Panka, W. Wang, M. Siddiqui, N. Tawa, J. Mullen, S. Tahan, L. Mandato, A. Polivy, J. Mier, et al. Effect of Melanoma on Immune Function in the Regional Lymph Node Basin Clin. Cancer Res., February 1, 2008; 14(3): 654 - 659. [Abstract] [Full Text] [PDF]

				L. O'Mahony, L. O'Callaghan, J. McCarthy, D. Shilling, P. Scully, S. Sibartie, E. Kavanagh, W. O. Kirwan, H. P. Redmond, J. K. Collins, et al. Differential cytokine response from dendritic cells to commensal and pathogenic bacteria in different lymphoid compartments in humans Am J Physiol Gastrointest Liver Physiol, April 1, 2006; 290(4): G839 - G845. [Abstract] [Full Text] [PDF]

				A. S. Kadish, P. Timmins, Y. Wang, G. Y. F. Ho, R. D. Burk, J. Ketz, W. He, S. L. Romney, A. Johnson, R. Angeletti, et al. Regression of Cervical Intraepithelial Neoplasia and Loss of Human Papillomavirus (HPV) Infection Is Associated with Cell-mediated Immune Responses to an HPV Type 16 E7 Peptide Cancer Epidemiol. Biomarkers Prev., May 1, 2002; 11(5): 483 - 488. [Abstract] [Full Text] [PDF]

				P. Mulders, C.-L. Tso, B. Gitlitz, R. Kaboo, A. Hinkel, S. Frand, S. Kiertscher, M. D. Roth, J. deKernion, R. Figlin, et al. Presentation of Renal Tumor Antigens by Human Dendritic Cells Activates Tumor-infiltrating Lymphocytes against Autologous Tumor: Implications for Live Kidney Cancer Vaccines Clin. Cancer Res., February 1, 1999; 5(2): 445 - 454. [Abstract] [Full Text] [PDF]

				M. W. Bennett, J. O'Connell, G. C. O'Sullivan, C. Brady, D. Roche, J. K. Collins, and F. Shanahan The Fas Counterattack In Vivo: Apoptotic Depletion of Tumor-Infiltrating Lymphocytes Associated with Fas Ligand Expression by Human Esophageal Carcinoma J. Immunol., June 1, 1998; 160(11): 5669 - 5675. [Abstract] [Full Text] [PDF]